检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:潘红阳[1,2] 张昕霞 翁媛媛[1] 周韧[1] Pan Hongyang Zhang Xinxia Weng Yuanyuan Zhou Ren(Department of Pathology and Pathophysiology, Institute of Pathology and Forensic Medicine, Zhejiang University School of Medicine, Hangzhou 310058, China)
机构地区:[1]浙江大学病理学与法医研究所浙江大学病理学与病理生理学系,杭州310058 [2]宜康(杭州)生物技术有限公司
出 处:《中华病理学杂志》2016年第12期844-849,共6页Chinese Journal of Pathology
摘 要:目的开发制备GCET2兔单克隆抗体,研究其在弥漫性大B细胞淋巴瘤(DLBCL)诊断中的应用。方法采用兔单克隆抗体技术制备GCET2兔单克隆抗体;经免疫印迹、免疫组织化学(IHC)、免疫细胞化学和流式细胞术等方法鉴定其特异性;并用IHC法,检测GCET2与其他DLBCL诊断相关标志物(CD10、bcl-6、MUM1、GCET1、FOXP1、Ki-67和CMYC)在81例DLBCL、5例滤泡细胞淋巴瘤和2例Burkitt淋巴瘤临床样本组织中的表达。结果GCET2(EP316)抗体能特异性识别生发中心B细胞及其来源的肿瘤组织和细胞系(Raji、Daudi和Ramos)中的GCET2蛋白;对81例DLBCL进行检测,GCET2的阳性率达到43.2%(35/81),明显高于其他生发中心标志物的阳性检出率。此外,CMYC高表达DLBCL样本在GCET2阴性表达和阳性表达样本中所占比例分别为15.2%(7/46)和2.8%(1/35)。结论本研究制备的GCET2(EP316)抗体具有良好的特异性,是一种敏感的生发中心B细胞标记抗体。GCET2与其他分子标志物联用,可能有助于提高对生发中心B细胞型DLBCL的检测敏感性。Objective To prepare a rabbit monoelonal antibody GCET2 and to investigate its diagnostic value in the workup of diffuse large B-cell lymphoma ( DLBCL ) . Methods GCET2 rabbit monoclonal antibody was developed by using RabMAb technology, and its specificity was confirmed by ELISA, Western blot, immunohistoehemistry (IHC) and flow eytometry. A panel of immunomarkers including GCET2, CD10, bel-6, MUM1, GCET1, FOXP1 , Ki-67 and CMYC was evaluated in 81 cases of DLBCLs, 5 cases of follicular lymphomas (FL) and 2 cases of Burkitt's lymphomas. Results Rabbit monoelonal GCET2 antibody (clone EP316 ) was developed with specificity for normal germinal center B-cells (GCB) and GCB origined lymphomas. In 81 cases of DLBCL, the positive rate of GCET2 was 43.2% (35/81), which was significantly higher than that of other germinal center markers. Moreover, among 81 DLBCLs, the proportions of high CMYC expression in GCET2 negative and positive groups were 15.2% (7/46) and 2. 8% ( 1/35 ), respectively. Conclusion GCET2 is a sensitive immunohistochemical marker for GCB derived lymphomas. Combined with other biomarkers, it may improve the diagnostic sensitivity of GCB-DLBCL.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15